In our patient, a genetic component seems to be obvious, but neither genetic alterations coinciding with Li-Fraumeni-like syndrome (p53 tumour suppressor pathway) nor mutations of the retinoblastoma gene 1 could be found. The gene discussed is TP53; the disease is Li-fraumeni-like syndrome.